New cancer clinical trial: Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Published on: April 23, 2018 at 12:00PM
Conditions:   Differentiated Thyroid Gland Carcinoma;   Thyroid Gland Follicular Carcinoma;   Thyroid Gland Papillary Carcinoma
Intervention:   Drug: Lenvatinib
Sponsors:   Emory University;   Eisai Inc.
Not yet recruiting
https://ift.tt/2vCuzVK